Warning American Woodmark (AMWD) optimists! William Brandt just Sold 12,000 shares.; 5 Analysts Bullish Nabriva Therapeutics plc (NBRV)

January 12, 2018 - By Adrian Mccoy

Major shareholder, William Brandt is the American Woodmark Corp’s insider which unloaded shares of American Woodmark Corp, 12,000 to be precise. William Brandt’s shares were estimated based on $132.1, with the insider sale transaction valued at $1,584,949 U.S Dollars. This is not his first insider trade, in the last 30 days, he unloaded another 21,000 shares worth $2,702,671 USD. Currently, Mr. William, owns 1.75 million shares, which accounts for 10.92% of the company’s market cap. The insider’s activity definitely generated quite an interest in the stock community.

Among 5 analysts covering Nabriva Therapeutics (NASDAQ:NBRV), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Nabriva Therapeutics had 8 analyst reports since October 12, 2015 according to SRatingsIntel. The stock of Nabriva Therapeutics plc (NASDAQ:NBRV) earned “Outperform” rating by RBC Capital Markets on Tuesday, October 13. The stock of Nabriva Therapeutics plc (NASDAQ:NBRV) has “Outperform” rating given on Tuesday, October 13 by Leerink Swann. On Monday, October 12 the stock rating was initiated by Needham with “Buy”. The stock of Nabriva Therapeutics plc (NASDAQ:NBRV) earned “Outperform” rating by RBC Capital Markets on Thursday, November 12. The rating was initiated by Wedbush with “Outperform” on Tuesday, October 13. Leerink Swann reinitiated Nabriva Therapeutics plc (NASDAQ:NBRV) on Thursday, October 27 with “Outperform” rating. The firm earned “Buy” rating on Wednesday, January 27 by Gabelli. On Wednesday, February 1 the stock rating was maintained by Wedbush with “Outperform”. See Nabriva Therapeutics plc (NASDAQ:NBRV) latest ratings:

Nabriva Therapeutics plc, a clinical stage biopharmaceutical company, engages in the research and development of novel antibiotics to treat serious bacterial infections with a focus on the pleuromutilin class of antibiotics. The company has market cap of $226.75 million. The Company’s lead product candidate is lefamulin, a novel semi-synthetic pleuromutilin antibiotic for systemic administration in humans. It currently has negative earnings. The companyÂ’s product, lefamulin is being studied in two registrational Phase 3 clinical trials in patients with moderate to severe community-acquired bacterial pneumonia.

The stock decreased 0.48% or $0.03 during the last trading session, reaching $6.18. About 70,300 shares traded. Nabriva Therapeutics plc (NASDAQ:NBRV) has risen 15.31% since January 12, 2017 and is uptrending. It has underperformed by 1.39% the S&P500.

Since July 28, 2017, it had 0 buys, and 17 selling transactions for $5.40 million activity. On Monday, October 9 the insider BRANDT WILLIAM F sold $192,000. HENDRIX DANIEL T had sold 3,000 shares worth $241,896 on Tuesday, August 29. The insider DAVIS JAMES G sold 1,120 shares worth $100,639. 500 shares were sold by Dunston Steven Cary, worth $40,275 on Monday, August 28. 3,000 American Woodmark Corporation (NASDAQ:AMWD) shares with value of $267,868 were sold by Campbell Roger Perry. Tang Vance W sold $153,093 worth of American Woodmark Corporation (NASDAQ:AMWD) on Friday, September 15.

Investors sentiment decreased to 1.23 in Q3 2017. Its down 0.38, from 1.61 in 2017Q2. It turned negative, as 22 investors sold American Woodmark Corporation shares while 47 reduced holdings. 17 funds opened positions while 68 raised stakes. 13.00 million shares or 0.07% less from 13.01 million shares in 2017Q2 were reported. California State Teachers Retirement System owns 22,587 shares or 0% of their US portfolio. Renaissance Technology Limited Liability Com reported 0.07% stake. Qs Invsts Limited Liability Co has 0% invested in American Woodmark Corporation (NASDAQ:AMWD). Wells Fargo & Mn holds 34,354 shares. One National Association, New York-based fund reported 7,343 shares. Brinker Cap owns 2,434 shares. Voya Mngmt Lc holds 0% or 13,836 shares in its portfolio. First American State Bank accumulated 0.02% or 2,555 shares. Savings Bank Of Montreal Can owns 0% invested in American Woodmark Corporation (NASDAQ:AMWD) for 16,710 shares. Alliancebernstein L P reported 42,800 shares stake. Stifel Financial Corporation holds 0.06% or 189,755 shares in its portfolio. Alps Inc owns 5,236 shares or 0% of their US portfolio. Meeder Asset owns 405 shares or 0% of their US portfolio. National Bank Of America Corporation De reported 38,858 shares. The Massachusetts-based Wellington Group Ltd Liability Partnership has invested 0.01% in American Woodmark Corporation (NASDAQ:AMWD).

American Woodmark Corporation manufactures and distributes kitchen cabinets and vanities for the remodeling and home construction markets in the United States. The company has market cap of $2.13 billion. The firm offers framed stock cabinets in approximately 514 various cabinet lines, which include 85 door creates in a range of painted and stained finishes on maple, cherry, and oak, as well as engineered fronts under the Duraform mark name. It has a 29.31 P/E ratio. It offers cabinets in various sizes, and construction and decorative options for a range of design layouts; and turnkey installation services to its direct builder clients through a network of seven service centers.

Analysts await American Woodmark Corporation (NASDAQ:AMWD) to report earnings on February, 26. They expect $0.89 earnings per share, 0.00% or $0.00 from last year’s $0.89 per share. AMWD’s profit will be $14.28M for 37.28 P/E if the $0.89 EPS becomes a reality. After $1.23 actual earnings per share reported by American Woodmark Corporation for the previous quarter, Wall Street now forecasts -27.64% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News